Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
8 8 Search
2025
Current status of drug therapy for chronic hepatitis B
World Journal of Gastroenterology
2024
Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
World Journal of Hepatology
2023
Long-Term Hepatitis B Surface Antigen Profile and Seroclearance Following Antiviral Treatment: A Single-Center, Real-World Cohort Study
Biomedicines
2022
HERACLIS‐TAF: a multi‐centre prospective cohort study on 2‐year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks
Alimentary Pharmacology & Therapeutics
2022
Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B
Alimentary Pharmacology & Therapeutics
2022
Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis
Journal of Clinical Medicine
2022
Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients—author's reply
Alimentary Pharmacology & Therapeutics
2022
Comparison of the side effects of antivirals in chronic hepatitis B patients: a single-center experience
Acta Gastro Enterologica Belgica